Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin - Wikidata - awgldk - TriplyDB

Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin

Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin

http://www.wikidata.org/entity/Q24644694

about

The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding Structure of Myostatin·Follistatin-like 3 GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers Effects of activin A on survival, function and gene expression of pancreatic islets from non-diabetic and diabetic human donors A time- and matrix-dependent TGFBR3-JUND-KRT5 regulatory circuit in single breast epithelial cells and basal-like premalignancies Overexpression of follistatin in the mouse epididymis disrupts fluid resorption and sperm transit in testicular excurrent ducts Follistatin promotes adipocyte differentiation, browning, and energy metabolism Cell lineages and the logic of proliferative control Redundancy of myostatin and growth/differentiation factor 11 function Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer.Keratinocyte-derived follistatin regulates epidermal homeostasis and wound repair.Emodin prevents hypoxic-ischemic neuronal injury: Involvement of the activin A pathway.Inhibin at 90: from discovery to clinical application, a historical review Spatial dynamics of multistage cell lineages in tissue stratification.METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11.Follistatin regulates germ cell nest breakdown and primordial follicle formation.Extracellular Regulation of Myostatin: A Molecular Rheostat for Muscle Mass.Activin and GDF11 collaborate in feedback control of neuroepithelial stem cell proliferation and fate.Differential synthesis and action of TGFß superfamily ligands in mouse and rat islets Production of bioactive chicken (Gallus gallus) follistatin-type proteins in E. coli Characterization of follistatin-type domains and their contribution to myostatin and activin A antagonism.Activin B regulates islet composition and islet mass but not whole body glucose homeostasis or insulin sensitivity Mammalian target of rapamycin (mTOR) signaling network in skeletal myogenesis.Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice.Increased activin bioavailability enhances hepatic insulin sensitivity while inducing hepatic steatosis in male mice.The biology of activin: recent advances in structure, regulation and function Modulators of erythropoiesis: emerging therapies for hemoglobinopathies and disorders of red cell production.Role of activin in bacterial infections: a potential target for immunointervention?Activins and Inhibins: Roles in Development, Physiology, and Disease.Structural Biology and Evolution of the TGF-β Family Differential Binding Activity of TGF-β Family Proteins to Select TGF-β Receptors.L6E9 myoblasts are deficient of myostatin and additional TGF-beta members are candidates to developmentally control their fiber formation.Follistatin N terminus differentially regulates muscle size and fat in vivo.Foxg1 promotes olfactory neurogenesis by antagonizing Gdf11.Emerging roles for the TGFbeta family in pancreatic beta-cell homeostasis.Overexpression of follistatin in trout stimulates increased muscling.Endothelial cells enhance adipose mesenchymal stromal cell-mediated matrix contraction via ALK receptors and reduced follistatin: Potential role of endothelial cells in skin fibrosis.A targeted proteomic assay for the measurement of plasma proteoforms related to human aging phenotypes.

P2860

Q27656789-0C4DEBE7-41DB-4EF5-90AE-15A25937EB38 Q27675374-7199A9F6-FC05-494F-A409-A290D19CA8ED Q28262319-16D85C7C-7729-4DA0-8DE4-42EE98E3C1BD Q30276341-61E18532-6D1B-4694-B31D-3E148981F7C8 Q30359879-250A776A-D075-4AAB-8EEB-7A929FDD696F Q30410515-7D81F130-81F6-438D-BDBD-3062CA13273F Q30417842-295FAB19-4314-4FD7-B900-7F3C5EF2F04F Q30572723-F0175529-D166-4DAB-8E22-48FC2E6E3FE4 Q33402595-C030A7A8-8B0E-4566-AE53-9C0CF4A1EAA0 Q33419706-64BCC626-3AB0-4685-BBBC-00925519472E Q33768293-9C79335D-6043-4532-8E18-A70BE1149512 Q33864873-F207894D-BA8E-4E3C-A945-76D25EC61F00 Q33937600-101367BF-1152-4202-A51A-4CB07CBF76C5 Q34204531-81E66A4D-13C1-4601-8404-4DEE0008446A Q34307059-DDD65794-1689-429D-BFD4-DAB278A325CB Q34447001-FF0A7F9F-621F-4015-B2B5-29B444EEC578 Q34566593-EEC18443-77F7-4EE9-AA6E-A7BCC2F2F097 Q34694932-68C16EBA-5711-4B49-A3CC-874D275EBFBC Q35208698-7A78B7D5-9190-4B5C-8715-EC6E0EA232CC Q35897315-A15888E5-1CF2-43EC-94F7-DB6C84BC2F89 Q35991903-2F0FFC39-BC79-40FD-9646-29D4C4392172 Q36065507-091FC9DD-306F-4CDA-AFCA-6DAB963534F6 Q36309428-CEDDC2D1-30C7-42C6-A98E-BE07C05F5223 Q36481912-B915AB7C-205E-4D21-8717-FCC798117DA6 Q36625078-5AB60F6E-5833-419F-8E12-07F400530298 Q37087710-FDE78B8E-4614-4726-8CAB-D04C94517C7D Q37247171-A03DB7D0-5CF9-46FB-94A5-BE821D67E9B1 Q37673351-80C9E829-EBBA-40FB-B748-8D22229648B7 Q37793227-538C2E7C-9B80-4627-A7AF-468CB62C5982 Q38872337-0348C304-D4C8-4CF7-8E6F-79A6AEB8E478 Q38957057-86651042-7E1D-4898-8FB4-90E1B135C175 Q39658022-11369EEA-3D1F-4310-87B9-522D8DE964B9 Q39714216-FFFFB252-DBDF-4220-BDA6-A83330125A81 Q40040011-173FF142-29F5-4B7B-A0AA-1E4E45828002 Q42054128-30E4955F-7ABB-4A1E-A657-E8AF97D3940A Q42113167-F436FE9F-F6D4-4405-90A3-A29C0C688E7E Q47712339-B0D373EA-E9BE-4898-8C20-DF49E52B63EB Q49973934-AD6EC0AB-7CBF-4FCE-9356-6B8869C00C2D Q50999277-3437CAE0-071D-4FD2-A62F-99127232CB9D

P2860

Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin

http://www.wikidata.org/entity/Q24644694

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Differential antagonism of act ...... ld-type and mutant follistatin

@ast

Differential antagonism of act ...... ld-type and mutant follistatin

@en

Differential antagonism of act ...... ld-type and mutant follistatin

@nl

type

label

Differential antagonism of act ...... ld-type and mutant follistatin

@ast

Differential antagonism of act ...... ld-type and mutant follistatin

@en

Differential antagonism of act ...... ld-type and mutant follistatin

@nl

prefLabel

Differential antagonism of act ...... ld-type and mutant follistatin

@ast

Differential antagonism of act ...... ld-type and mutant follistatin

@en

Differential antagonism of act ...... ld-type and mutant follistatin

@nl

P1433

Q24644694-4CEFD789-2BDC-473C-93E2-0AEC48213FCA

P1476

Q24644694-B3C2D909-C35A-470A-B695-4ACFC7366C0C

P2093

Q24644694-81738318-A15E-407B-8D4F-962D00AB0BBA

Q24644694-AED6747A-930D-49E3-86F7-EF6D8E9D0D8D

Q24644694-B0BD200B-0264-4103-B2EE-949583299856

Q24644694-C1D37A61-08C2-4486-8440-40B52F235136

Q24644694-D5226BA2-194E-493A-B7E9-D299AB847BB2

Q24644694-F7617038-422D-4F52-9B15-208865C318BA

P2860

Q24644694-1F65A03B-5108-4A1E-8F9C-DE654A269ABE

Q24644694-20134F08-8DA9-444B-BD3D-ECA61AEF1AE8

Q24644694-2154617B-30EF-4909-BE87-5B97B3DE10E5

Q24644694-2C2B43A8-61D1-412E-B75D-1518A6C0AAD2

Q24644694-39EF80EA-EC17-45EF-8DE6-F2D4206CE458

Q24644694-5BDFE3B2-61C6-49C7-96EA-0815189D93E9

Q24644694-5CE23C96-CC59-4C02-A1F9-5CD274217D87

Q24644694-5E93B884-4E0A-4933-B9EF-39AB91CAD7CF

Q24644694-6242132C-B291-4AE1-A9DD-AA1BFFB0BDAE

Q24644694-6B482A27-2E63-4B52-B5EA-438DFD90DEBB

P304

Q24644694-714B05C6-3CA3-43CC-A66A-C99760548543

P31

Q24644694-B0B305D5-E1F2-467A-90FB-BFE60AA00426

P3181

Q24644694-79B0FECD-3E32-442A-B231-0B3E1CAD5ED4

P356

Q24644694-4575EB0C-B952-487F-AE5C-E99339597B82

P407

Q24644694-1CC1B1C9-9A4A-415C-BDB7-69646EE12107

P433

Q24644694-E837AB11-5F2E-40C6-BFA4-2DBDB7F4E3C0

P478

Q24644694-40A30235-2B93-4DD2-A617-096DBB11E42A

P577

Q24644694-B33EED99-0B3F-4DB0-92A5-9DE5C7F3377D

P5875

Q24644694-C74F5D08-8741-4CF1-98BA-6FD029A9ED25

P698

Q24644694-82688CD7-1238-40A7-9F44-9EA26F638D76

P932

Q24644694-9B279EDC-7FBB-488E-9BCD-72AE9107D73F

P3181

P356

P1433

P1476

Differential antagonism of act ...... ld-type and mutant follistatin

@en

P2093

Alan L Schneyer

http://www.w3.org/2001/XMLSchema#string

Anisha Gulati

http://www.w3.org/2001/XMLSchema#string

Henry Keutmann

http://www.w3.org/2001/XMLSchema#string

Jie L Sun

http://www.w3.org/2001/XMLSchema#string

Philip A Krasney

http://www.w3.org/2001/XMLSchema#string

Yisrael Sidis

http://www.w3.org/2001/XMLSchema#string

P2860

Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting

Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium

The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding

Regulation of myostatin activity and muscle growth

Human follistatin-related protein: a structural homologue of follistatin with nuclear localization

Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins

Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member

Overexpression of follistatin-like 3 in gonads causes defects in gonadal development and function in transgenic mice

Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice

GDF11 modulates NGN3+ islet progenitor cell number and promotes beta-cell differentiation in pancreas development

P304

4589-95

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1974366

http://www.w3.org/2001/XMLSchema#string

P356

10.1210/EN.2008-0259

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

149

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5322720

http://www.w3.org/2001/XMLSchema#string

P698

18535106

http://www.w3.org/2001/XMLSchema#string

P932

2553374

http://www.w3.org/2001/XMLSchema#string